Although we know that semaglutide helps people lose weight, there arent yet any big clinical trials to tell us whether this weight loss leads to reductions in heart disease and stroketwo conditions that are strongly linked to obesity
Blood 117 , 60246035 (2011)
Until the last decade or so, says Fanelli, retractions didnt receive much publicity
This was shown in a prospective, randomized, double-blind, placebo-controlled, crossover study in 30 subjects free of metabolic conditions
Several studies exposed primary microglia to -syn monomers or high-ordered oligomers
MeSH-controlled vocabulary terms and related keywords were combined using appropriate Boolean operators to find literature either investigating or discussing incretin-based drugs (GLP-1R agonists and DPP4-inhibitors) for the treatment of neurodegenerative diseases, particularly glaucoma, diabetic retinopathy, AMD, Alzheimers disease, Parkinsons disease, stroke and neuropathy